Alembic Ltd. |
Payback time |
Not Rated
CMP: Rs 63 Target Price: NR
n De-merger to insulate core pharma business from the volatility of the Pen G business
n Real estate development presents strong value unlocking potential
n Growth drivers for pharma are in place; strong growth trajectory ahead
n Significant room for margin expansion.
n Trading at 30-40% discount to comparable peers; provides substantial room for upside
No comments:
Post a Comment